Revolution Medicines is a clinical-stage precision oncology company seeking a National Account Director, Academic/IDN Oncology to establish and maintain strategic relationships with Large Health Systems, Integrated Delivery Networks, and key stakeholders to secure optimal market access for innovative oncology medicines.
Requirements
- Translate national, brand-level strategy to targeted Large Health Systems, IDNs, and key KOL/Pharmacy decision makers.
- Lead and oversee account activities such as driving rapid formulary, clinical pathway, and treatment protocol inclusion post-launch in close collaboration with Medical Affairs.
- Build and maintain strong KOL and C-level relationships with aligned IDN and large system accounts.
- Analyze business opportunities to proactively provide strategic and tactical guidance.
- Negotiate favorable contracts and agreements.
- Create medium to long-term strategic engagement plan spanning multiple product and indication launches and focuses on engaging beyond transactional approaches.
- Facilitate executive exchanges to create opportunities for Rev Med leaders and IDN/C-Suite leaders to meet and align.
- Identify the overlap between customer needs and Rev Med needs to build collaborative business solutions.
- Champion voice of customer to internal stakeholders and commercial leadership.
- Track and analyze account performance and identify areas for improvement.
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities